DocDollars

Beigene Switzerland GMBH

Switzerland · Reporting entity ID 100000826835

Total reported 2019–2025
$7.02M
#600 of 2,960 reporting companies — 0% of all reported industry payments
$253K in general payments across 82 records, plus $6.77M in research funding across 97 records.

How it breaks down

General payments $253,450
Research funding $6,770,106

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Beigene Switzerland GMBH reported $7.02M to US doctors and teaching hospitals from 2019 to 2025, ranking #600 of 2,960 reporting companies. 96% of that was research funding and 4% general payments such as consulting, speaking, food and travel. 82 general payment records and 97 research records were filed.

Common questions about Beigene Switzerland GMBH

How much has Beigene Switzerland GMBH paid US doctors?

Beigene Switzerland GMBH reported $7,023,556 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $253,450 in general payments, $6,770,106 in research funding.

How does Beigene Switzerland GMBH rank among drug and device companies?

It ranks #600 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Beigene Switzerland GMBH mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.